1-2 of 2
Chiara Trotti, MD
Close
Sort by
Journal Articles

Direct Oral Anticoagulants for Myeloproliferative Neoplasms (MPN-DOACs): Results from an International Study on 442 Patients

Tiziano Barbui, MD, Valerio De Stefano, MD, Alessandra Carobbio, BSc, Alessandra Iurlo, MD PhD, Alberto Alvarez-Larran, MD, Alessandro M. Vannucchi, MD, Francesca Palandri, MD PhD, Claire Harrison, DM, FRCP, FRCPath, Hassan Sibai, MBBS, Martin Griesshammer, MD PhD, Massimiliano Bonifacio, MD, Elena M Elli, MD, Chiara Trotti, MD, Steffen Koschmieder, MD, Giuseppe Carli, MD, Giulia Benevolo, Jean-Christophe Ianotto, MD PhD, Swati Goel, MD, Anna Falanga, MD, Silvia Betti, MD PhD, Daniele Cattaneo, MD, Eduardo Arellano-Rodrigo, MD, Lara Mannelli, MD, Nicola Vianelli, MD, Andrew Doyle, MBBS, BSc, FRPATH, Vikas Gupta, MD FRCP, FRCPath, Kai Wille, MD, Douglas Tremblay, MD, John Mascarenhas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-139229
Published: 2020
Journal Articles

Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib

Elisa Rumi, MD, Chiara Cavalloni, MD, Giuditta Comolli, Virginia Valeria Ferretti, Irene Cassaniti, Daniela Pietra, PhD, Chiara Trotti, MD, Michele Ciboddo, MD, Melania Degli Antoni, Milena Furione, Fausto Baldanti, MD, Luca Arcaini, Mario Cazzola, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1660.
https://doi.org/10.1182/blood-2019-127994
Published: 2019